by HTLV | Aug 27, 2026 | Publications
Pathogens. 2026 Jul 28;15(8):800. doi: 10.3390/pathogens15080800. ABSTRACT Oncogenic viruses contribute to approximately 20% of human cancers globally, with their impact falling disproportionately on populations in Sub-Saharan Africa. In this region, cervical cancer,...
by HTLV | Aug 27, 2026 | Publications
Viruses. 2026 Aug 12;18(8):882. doi: 10.3390/v18080882. ABSTRACT Human T-cell lymphotropic virus type 1 (HTLV-1) is a neglected pathogen with a heterogeneous global distribution. In low-prevalence areas, diagnostic testing is challenged by limited clinical awareness...
by HTLV | Aug 27, 2026 | Publications
Tumour Virus Res. 2026 Aug 26:200349. doi: 10.1016/j.tvr.2026.200349. Online ahead of print. ABSTRACT Adult T-cell leukemia (ATL) is a rare but aggressive CD4+CD25+ leukemia triggered by HTLV-1 infection. We quantified ex vivo levels of CD4+ and CD8+ (sub)populations...
by HTLV | Aug 26, 2026 | Publications
Immunol Res. 2026 Aug 26;74(1):97. doi: 10.1007/s12026-026-09833-8. ABSTRACT Human T-cell lymphotropic virus type 1 (HTLV-1) is a persistent human retrovirus associated with severe outcomes, most notably adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated...
by HTLV | Aug 25, 2026 | Publications
PLoS Pathog. 2026 Aug 25;22(8):e1014512. doi: 10.1371/journal.ppat.1014512. Online ahead of print. ABSTRACT Over the recent years, reports of very high prevalences of Human T-cell Leukemia Virus (HTLV) type 1 genotype c infection in remote aboriginal populations in...
by HTLV | Aug 20, 2026 | Publications
Biochem Biophys Res Commun. 2026 Aug 8;834:154414. doi: 10.1016/j.bbrc.2026.154414. Online ahead of print. ABSTRACT Human T-cell Leukemia Virus Type 1 (HTLV-1) protease (PR) is a critical enzyme involved in viral maturation and represents a key target for the...
